help button home button The Oncologist http://theoncologist.alphamedpress.org/subscriptions/etoc.dtl
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
The Oncologist, Vol. 11, No. 6, 681-693, June 2006; doi:10.1634/theoncologist.11-6-681
© 2006 AlphaMed Press

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
 Low-Grade Gliomas in Adults
Right arrow eLetters: Submit a response to this article
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Grier, J. T.
Right arrow Articles by Batchelor, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grier, J. T.
Right arrow Articles by Batchelor, T.

Neuro-Oncology

Low-Grade Gliomas in Adults

Jeanine T. Grier, Tracy Batchelor

Division of Neuro-Oncology, Department of Neurology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA

Key Words. Low-grade glioma • Astrocytoma • Oligodendroglioma

Correspondence: Tracy Batchelor, M.D., M.P.H., Stephen E. and Catherine Pappas Center for Neuro-Oncology, Yawkey 9E, Massachusetts General Hospital, 55 Fruit Street, Boston, Massachusetts 02114, USA. Telephone: 617-643-1938; Fax: 617-643-2591; e-mail: tbatchelor{at}partners.org

Low-grade gliomas are a heterogeneous group of neoplasms usually encountered in younger patient populations. These tumors represent a unique challenge because most patients will survive a decade or more and may be at a higher risk for treatment-related complications. Clinical observations over the years have identified a subset of low-grade gliomas that tends to manifest more aggressive clinical behavior and require earlier, more aggressive intervention. Clinical and molecular parameters may allow better assessment of prognosis and application of risk-adjusted management strategies that may include resection, radiation, or chemotherapy. Improved methods of long-term cognitive and functional assessment are desperately needed in this patient population.




This article has been cited by other articles:


Home page
 RadiologyHome page
K. E. Emblem, B. Nedregaard, T. Nome, P. Due-Tonnessen, J. K. Hald, D. Scheie, O. C. Borota, M. Cvancarova, and A. Bjornerud
Glioma Grading by Using Histogram Analysis of Blood Volume Heterogeneity from MR-derived Cerebral Blood Volume Maps
Radiology, June 1, 2008; 247(3): 808 - 817.
[Abstract] [Full Text] [PDF]

Home page
 JCOHome page
J. S. Smith, E. F. Chang, K. R. Lamborn, S. M. Chang, M. D. Prados, S. Cha, T. Tihan, S. VandenBerg, M. W. McDermott, and M. S. Berger
Role of Extent of Resection in the Long-Term Outcome of Low-Grade Hemispheric Gliomas
J. Clin. Oncol., March 10, 2008; 26(8): 1338 - 1345.
[Abstract] [Full Text] [PDF]


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS
http://theoncologist.alphamedpress.org/misc/eLetters.shtml

Copyright © 2006 by AlphaMed Press.